No new cases in 188 districts in a week, 18 covid vaccine candidates in the pipeline: Health Minister

Union Health Minister Harsh Vardhan said on Monday that 18-19 potential vaccines against novel coronavirus were in different stages of clinical trials, adding that no new cases of COVID-19 have been reported in 188 districts of the country in the last 7 days.

"About 18-20 vaccine candidates against COVID-19 are in the pipeline and are in preclinical, clinical and advanced stages," Vardhan said.

"Some are in Phase I, some in Phase II, and a few approaching Phase III of the clinical trials. We are elated to have a huge portfolio soon," he said at a press conference here.

Dispelling rumours surrounding the vaccines, Vardhan said the vaccines in the public domain are safe and effective. He said no new cases of COVID-19 have been reported in 188 districts of the country in the last 7 days, while no new cases have been reported in 21 districts in 21 days.

Vardhan further urged people to keep following COVID appropriate behaviour. "It is crucial that people continue to follow COVID appropriate behaviour which I call social vaccine, along with real vaccines," he said. India has approved two vaccines -- Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India -- for emergency use in the country.

Till 8 AM on February 15, the cumulative number of healthcare workers (HCW) and frontline workers (FLW) vaccinated against COVID-19 in the country has reached nearly 83 lakh.

A total 82,85,295 beneficiaries have been vaccinated through 1,73,729 sessions, as per the provisional report till 8 am. These include 59,88,113 HCWs (1st dose), 24,561 HCWs (2nd dose) and 22,72,621 FLWs (1stdose).

India's cumulative recoveries have surged to 1,06,21,220 with9,489patients having recuperated in a span of 24 hours. The ministry said 79.5 per cent of the new recovered cases are observed to be concentrated in six states.

The Union government has prioritised vaccination of 30 crore Indians, dividing them into three categories -- one crore healthcare workers, 2 crore frontline workers, and 27 crores general populace above the age of 50.

On January 3, the Drugs Controller General of India had approved 'Covishield' vaccine developed by Pune-based Serum Institute of India and 'Covaxin' of Bharat Biotech for emergency use authorisation in the country.

Both vaccines have been provided in the nationwide immunisation drive, that was kicked off on January 16. Till Sunday, more than 8 million (82,85,295) doses of vaccines had been administered across India.

(With inputs from agencies)